Large molecular forms of cholecystokinin circulating in humans

H. Y. Gaisano, W. Reilly, V. L W Go, D. Olivero, Laurence J Miller

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Molecular heterogeneity between cholecystokinin (CCK) present in humans and that present in the pig has been proposed. We recently demonstrated that CCK-8 exists in humans in form identical to the porcine peptide. The aims of this work were to evaluate the presence in human plasma of CCK forms larger than CCK-8 and to compare them with the well-characterized porcine forms. Antiserum (no. 4899) was raised in a New Zealand white rabbit immunized with porcine CCK-33 that had specificity for the 7 to 21 region of that peptide and that recognized molecules present in human plasma. To characterize these, postprandial human plasma was applied to an immunoaffinity column generated with this antiserum. Adsorbed peptides were eluted, concentrated on an octadecylsilane cartridge, separated by reversed-phase HPLC and gel filtration chromatography, and screened by cross-reacting and specific CCK and gastrin radioimmunoassay and CCK bioassay by quantification of amylase release by rat pancreatic acini. Two peptides were consistently identified that possessed CCK-like but not gastrin-specific immunoreactivity and CCK-like biological activity. These appeared to be similar in size to CCK-33 and intermediate in size between CCK-33 and CCK-8. Though analogous to porcine CCK based on antibody cross-reactivity and biological activity, the human peptides were heterogeneous from the porcine peptides based on differing chromatographic behavior.

Original languageEnglish (US)
Pages (from-to)148-153
Number of pages6
JournalPancreas
Volume1
Issue number2
StatePublished - 1986

Fingerprint

Cholecystokinin
Swine
Peptides
Gastrins
Immune Sera
Amylases
Human Activities
Biological Assay
Radioimmunoassay
Gel Chromatography
High Pressure Liquid Chromatography
Rabbits
Antibodies

ASJC Scopus subject areas

  • Gastroenterology
  • Endocrinology

Cite this

Gaisano, H. Y., Reilly, W., Go, V. L. W., Olivero, D., & Miller, L. J. (1986). Large molecular forms of cholecystokinin circulating in humans. Pancreas, 1(2), 148-153.

Large molecular forms of cholecystokinin circulating in humans. / Gaisano, H. Y.; Reilly, W.; Go, V. L W; Olivero, D.; Miller, Laurence J.

In: Pancreas, Vol. 1, No. 2, 1986, p. 148-153.

Research output: Contribution to journalArticle

Gaisano, HY, Reilly, W, Go, VLW, Olivero, D & Miller, LJ 1986, 'Large molecular forms of cholecystokinin circulating in humans', Pancreas, vol. 1, no. 2, pp. 148-153.
Gaisano HY, Reilly W, Go VLW, Olivero D, Miller LJ. Large molecular forms of cholecystokinin circulating in humans. Pancreas. 1986;1(2):148-153.
Gaisano, H. Y. ; Reilly, W. ; Go, V. L W ; Olivero, D. ; Miller, Laurence J. / Large molecular forms of cholecystokinin circulating in humans. In: Pancreas. 1986 ; Vol. 1, No. 2. pp. 148-153.
@article{0cb8c60fb84848ac93bfb1868395b0e8,
title = "Large molecular forms of cholecystokinin circulating in humans",
abstract = "Molecular heterogeneity between cholecystokinin (CCK) present in humans and that present in the pig has been proposed. We recently demonstrated that CCK-8 exists in humans in form identical to the porcine peptide. The aims of this work were to evaluate the presence in human plasma of CCK forms larger than CCK-8 and to compare them with the well-characterized porcine forms. Antiserum (no. 4899) was raised in a New Zealand white rabbit immunized with porcine CCK-33 that had specificity for the 7 to 21 region of that peptide and that recognized molecules present in human plasma. To characterize these, postprandial human plasma was applied to an immunoaffinity column generated with this antiserum. Adsorbed peptides were eluted, concentrated on an octadecylsilane cartridge, separated by reversed-phase HPLC and gel filtration chromatography, and screened by cross-reacting and specific CCK and gastrin radioimmunoassay and CCK bioassay by quantification of amylase release by rat pancreatic acini. Two peptides were consistently identified that possessed CCK-like but not gastrin-specific immunoreactivity and CCK-like biological activity. These appeared to be similar in size to CCK-33 and intermediate in size between CCK-33 and CCK-8. Though analogous to porcine CCK based on antibody cross-reactivity and biological activity, the human peptides were heterogeneous from the porcine peptides based on differing chromatographic behavior.",
author = "Gaisano, {H. Y.} and W. Reilly and Go, {V. L W} and D. Olivero and Miller, {Laurence J}",
year = "1986",
language = "English (US)",
volume = "1",
pages = "148--153",
journal = "Pancreas",
issn = "0885-3177",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Large molecular forms of cholecystokinin circulating in humans

AU - Gaisano, H. Y.

AU - Reilly, W.

AU - Go, V. L W

AU - Olivero, D.

AU - Miller, Laurence J

PY - 1986

Y1 - 1986

N2 - Molecular heterogeneity between cholecystokinin (CCK) present in humans and that present in the pig has been proposed. We recently demonstrated that CCK-8 exists in humans in form identical to the porcine peptide. The aims of this work were to evaluate the presence in human plasma of CCK forms larger than CCK-8 and to compare them with the well-characterized porcine forms. Antiserum (no. 4899) was raised in a New Zealand white rabbit immunized with porcine CCK-33 that had specificity for the 7 to 21 region of that peptide and that recognized molecules present in human plasma. To characterize these, postprandial human plasma was applied to an immunoaffinity column generated with this antiserum. Adsorbed peptides were eluted, concentrated on an octadecylsilane cartridge, separated by reversed-phase HPLC and gel filtration chromatography, and screened by cross-reacting and specific CCK and gastrin radioimmunoassay and CCK bioassay by quantification of amylase release by rat pancreatic acini. Two peptides were consistently identified that possessed CCK-like but not gastrin-specific immunoreactivity and CCK-like biological activity. These appeared to be similar in size to CCK-33 and intermediate in size between CCK-33 and CCK-8. Though analogous to porcine CCK based on antibody cross-reactivity and biological activity, the human peptides were heterogeneous from the porcine peptides based on differing chromatographic behavior.

AB - Molecular heterogeneity between cholecystokinin (CCK) present in humans and that present in the pig has been proposed. We recently demonstrated that CCK-8 exists in humans in form identical to the porcine peptide. The aims of this work were to evaluate the presence in human plasma of CCK forms larger than CCK-8 and to compare them with the well-characterized porcine forms. Antiserum (no. 4899) was raised in a New Zealand white rabbit immunized with porcine CCK-33 that had specificity for the 7 to 21 region of that peptide and that recognized molecules present in human plasma. To characterize these, postprandial human plasma was applied to an immunoaffinity column generated with this antiserum. Adsorbed peptides were eluted, concentrated on an octadecylsilane cartridge, separated by reversed-phase HPLC and gel filtration chromatography, and screened by cross-reacting and specific CCK and gastrin radioimmunoassay and CCK bioassay by quantification of amylase release by rat pancreatic acini. Two peptides were consistently identified that possessed CCK-like but not gastrin-specific immunoreactivity and CCK-like biological activity. These appeared to be similar in size to CCK-33 and intermediate in size between CCK-33 and CCK-8. Though analogous to porcine CCK based on antibody cross-reactivity and biological activity, the human peptides were heterogeneous from the porcine peptides based on differing chromatographic behavior.

UR - http://www.scopus.com/inward/record.url?scp=0022897117&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022897117&partnerID=8YFLogxK

M3 - Article

C2 - 2437562

AN - SCOPUS:0022897117

VL - 1

SP - 148

EP - 153

JO - Pancreas

JF - Pancreas

SN - 0885-3177

IS - 2

ER -